Q2 EPS Forecast for Procter & Gamble Decreased by Analyst

The Procter & Gamble Company (NYSE:PGFree Report) – Research analysts at DA Davidson decreased their Q2 2025 earnings estimates for shares of Procter & Gamble in a research report issued on Monday, December 30th. DA Davidson analyst L. Weiser now anticipates that the company will earn $1.82 per share for the quarter, down from their previous forecast of $1.87. DA Davidson has a “Buy” rating and a $209.00 price objective on the stock. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.94 per share.

Several other research firms have also issued reports on PG. Evercore ISI increased their target price on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Wells Fargo & Company raised their target price on shares of Procter & Gamble from $188.00 to $190.00 and gave the company an “overweight” rating in a report on Friday, November 22nd. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. Morgan Stanley lifted their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Finally, Piper Sandler assumed coverage on Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price for the company. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $180.45.

View Our Latest Analysis on PG

Procter & Gamble Stock Performance

Shares of NYSE:PG opened at $167.09 on Tuesday. Procter & Gamble has a 12-month low of $146.28 and a 12-month high of $180.43. The company’s 50 day moving average price is $170.47 and its two-hundred day moving average price is $169.88. The firm has a market cap of $393.50 billion, a PE ratio of 28.81, a PEG ratio of 3.70 and a beta of 0.44. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter last year, the firm earned $1.83 earnings per share. The company’s revenue was down .6% on a year-over-year basis.

Hedge Funds Weigh In On Procter & Gamble

Hedge funds and other institutional investors have recently modified their holdings of the business. Acorn Creek Capital LLC grew its stake in shares of Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after purchasing an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. raised its position in shares of Procter & Gamble by 1.1% during the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock worth $963,000 after purchasing an additional 59 shares during the last quarter. Traveka Wealth LLC lifted its position in shares of Procter & Gamble by 1.7% in the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after acquiring an additional 60 shares in the last quarter. Allen Mooney & Barnes Investment Advisors LLC lifted its holdings in Procter & Gamble by 0.7% in the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock valued at $1,507,000 after purchasing an additional 61 shares in the last quarter. Finally, Valued Wealth Advisors LLC lifted its stake in shares of Procter & Gamble by 11.2% in the third quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock worth $105,000 after buying an additional 61 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling

In related news, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the transaction, the insider now owns 19,341 shares in the company, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 83,080 shares of company stock valued at $14,629,038. 0.18% of the stock is owned by company insiders.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.41%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s payout ratio is 69.31%.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Read More

Earnings History and Estimates for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.